311 related articles for article (PubMed ID: 23246968)
21. [mTOR inhibitor].
Muro K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
[TBL] [Abstract][Full Text] [Related]
22. Focus issue: TOR signaling, a tale of two complexes.
Gough NR
Sci Signal; 2012 Mar; 5(217):eg4. PubMed ID: 22457327
[TBL] [Abstract][Full Text] [Related]
23. The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation.
Bjedov I; Rallis C
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899412
[TBL] [Abstract][Full Text] [Related]
24. Current treatment strategies for inhibiting mTOR in cancer.
Chiarini F; Evangelisti C; McCubrey JA; Martelli AM
Trends Pharmacol Sci; 2015 Feb; 36(2):124-35. PubMed ID: 25497227
[TBL] [Abstract][Full Text] [Related]
25. Current and future directions in mammalian target of rapamycin inhibitors development.
Fasolo A; Sessa C
Expert Opin Investig Drugs; 2011 Mar; 20(3):381-94. PubMed ID: 21299441
[TBL] [Abstract][Full Text] [Related]
26. mTOR in health and in sickness.
Liko D; Hall MN
J Mol Med (Berl); 2015 Oct; 93(10):1061-73. PubMed ID: 26391637
[TBL] [Abstract][Full Text] [Related]
27. Use of mTOR inhibitors in the treatment of malignancies.
Mohindra NA; Giles FJ; Platanias LC
Expert Opin Pharmacother; 2014 May; 15(7):979-90. PubMed ID: 24666371
[TBL] [Abstract][Full Text] [Related]
28. TOR Complexes and the Maintenance of Cellular Homeostasis.
Eltschinger S; Loewith R
Trends Cell Biol; 2016 Feb; 26(2):148-159. PubMed ID: 26546292
[TBL] [Abstract][Full Text] [Related]
29. Mammalian target of rapamycin signaling in the podocyte.
Inoki K; Huber TB
Curr Opin Nephrol Hypertens; 2012 May; 21(3):251-7. PubMed ID: 22388550
[TBL] [Abstract][Full Text] [Related]
30. Functional consequences of mTOR inhibition.
Sudarsanam S; Johnson DE
Curr Opin Drug Discov Devel; 2010 Jan; 13(1):31-40. PubMed ID: 20047144
[TBL] [Abstract][Full Text] [Related]
31. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
32. Target of Rapamycin (TOR) Regulates Growth in Response to Nutritional Signals.
Weisman R
Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763256
[TBL] [Abstract][Full Text] [Related]
33. New inhibitors of the PI3K-Akt-mTOR pathway: insights into mTOR signaling from a new generation of Tor Kinase Domain Inhibitors (TORKinibs).
Feldman ME; Shokat KM
Curr Top Microbiol Immunol; 2010; 347():241-62. PubMed ID: 20549474
[TBL] [Abstract][Full Text] [Related]
34. Targeting PI3 kinase in cancer.
Bauer TM; Patel MR; Infante JR
Pharmacol Ther; 2015 Feb; 146():53-60. PubMed ID: 25240910
[TBL] [Abstract][Full Text] [Related]
35. Modulating mTOR in aging and health.
Johnson SC; Sangesland M; Kaeberlein M; Rabinovitch PS
Interdiscip Top Gerontol; 2015; 40():107-27. PubMed ID: 25341517
[TBL] [Abstract][Full Text] [Related]
36. mTOR kinase inhibitors as a treatment strategy in hematological malignancies.
Grzybowska-Izydorczyk O; Smolewski P
Future Med Chem; 2012 Mar; 4(4):487-504. PubMed ID: 22416776
[TBL] [Abstract][Full Text] [Related]
37. Targeting the mTOR pathway using deforolimus in cancer therapy.
Mahalingam D; Sankhala K; Mita A; Giles FJ; Mita MM
Future Oncol; 2009 Apr; 5(3):291-303. PubMed ID: 19374536
[TBL] [Abstract][Full Text] [Related]
38. [mTOR complexes -- molecular spiders in molecular networks].
Kopper L; Tímár J
Magy Onkol; 2011 Nov; 55(4):287-94. PubMed ID: 22128312
[TBL] [Abstract][Full Text] [Related]
39. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer.
Mabuchi S; Kuroda H; Takahashi R; Sasano T
Gynecol Oncol; 2015 Apr; 137(1):173-9. PubMed ID: 25677064
[TBL] [Abstract][Full Text] [Related]
40. Beyond control of protein translation: what we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR).
Malik AR; Urbanska M; Macias M; Skalecka A; Jaworski J
Biochim Biophys Acta; 2013 Jul; 1834(7):1434-48. PubMed ID: 23277194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
